2016 Hematological Malignancies
HD15 in advanced HL Overall Survival (OS @ 5yrs)
Overall Survival 0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 0
A: 91.9% B: 95.3% C: 94.5%
p-value
60 months difference
A vs. B : 0.02 A vs. C : 0.07 C vs. B : 0.6
3.3% 2.6% 0.7%
97.5%-CI: [ 0.2%, 6.5%]
[-0.6%, 5.9%] [-2.1%, 3.5%]
12
24
36
48
60
72
Time [months]
Engert A et al, Lancet 2012
Made with FlippingBook